Oscar Health, Inc. (OSCR): debt financing — Oscar Health reports record 3.4M members, FY2025 net loss $443M; guides FY2026 revenue $18.7-$19B

Oscar Health, Inc.

2025-FY EPS reported -$1.69 revenue$11,701,427,000

Full-year 2025 net loss $443.2M ($1.69 diluted EPS) vs prior-year net income $25.4M ($0.10 diluted EPS).
Record membership of ~3.4 million as of Dec 31, 2025, up from 1.68 million a year earlier.
FY2025 total revenue $11.7B (up 27% YoY); medical loss ratio 87.4% (vs 81.7% in 2024).
FY2026 guidance: revenue $18.7-$19.0B, MLR 82.4-83.4%, SG&A ratio 15.8-16.3%, operating earnings $250-$450M.
Entered into $475M secured three-year revolving credit facility (Feb 6, 2026) for general corporate purposes.

item 1.01 item 2.02 item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Oscar Health, Inc. incurred revolving credit of $475.0 million with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto at Term SOFR plus a margin of 4.50% per annum, or the Alternate Base Rate plus a ma maturing February 6, 2029.

Instrument: revolving credit
Principal: $475.0 million
Counterparty: JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto
Rate: Term SOFR plus a margin of 4.50% per annum, or the Alternate Base Rate plus a ma
Maturity: February 6, 2029
Event: incurrence

Exact text from the filing

On February 6, 2026, Oscar Health, Inc. (the “Company”), entered into a $475.0 million secured three-year revolving credit facility (the “Revolving Credit Facility”), pursuant to a Credit Agreement (the “Credit Agreement”), by and among the Company, certain subsidiaries of the Company, as subsidiary guarantors, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Oscar Health, Inc. entered into Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto valued at $475.0 million (effective 2026-02-06).

Action: entry
Agreement: credit facility
Counterparty: JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto
Value: $475.0 million
Effective: 2026-02-06

Exact text from the filing

On February 6, 2026, Oscar Health, Inc. (the “Company”), entered into a $475.0 million secured three-year revolving credit facility (the “Revolving Credit Facility”), pursuant to a Credit Agreement (the “Credit Agreement”), by and among the Company, certain subsidiaries of the Company, as subsidiary guarantors, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto.

View on SEC.gov

26 debt financings filed in the last 30 days. Browse all debt financings →

Oscar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001568651-26-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.